1. Aguilar-Lemarroy, A., P.Gariglio, N.J.Whitaker, S.T.Eichhorst, H.zurHausen, P.H.Krammer, and F.Rösl. 2002. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene. 21(2):165-175.
2. Akgul, B., J.C.Cooke, and A.Storey. 2006. HPV-associated skin disease. J Pathol. 208(2):165-175.
3. Akgul, B., R.Garcia-Escudero, L.Ghali, H.J.Pfister, P.G.Fuchs, H.Navsaria, and A.Storey. 2005. - The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 65(6):2216-2223.
4. Albini, A., Y.Iwamoto, H.K.Kleinman, G.R.Martin, S.A.Aaronson, J.M.Kozlowski, and R.N.McEwan. 1987. - A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47(12):3239-3245.
5. Ananthaswamy, H.N. and W.E.Pierceall. 1990. Molecular mechanisms of ultraviolet radiation carcinogenesis. Photochem Photobiol. 52(6):1119-1136.
6. Asbill, C., N.Kim, A.El-Kattan, K.Creek, P.Wertz, and B.Michniak. 2000. Evaluation of a human bio-engineered skin equivalent for drug permeation studies. Pharm Res. 17(9):1092-1097.
7. Baker, C.C., W.C.Phelps, V.Lindgren, M.J.Braun, M.A.Gonda, and P.M.Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61(4):962-971.
8. Banerjee, N.S., N.J.Genovese, F.Noya, W.M.Chien, T.R.Broker, and L.T.Chow. 2006. Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J. Virol. 80(13):6517-6524.
9. Bavinck, J.N., B.A.De, B.J.Vermeer, M.M.Hartevelt, F.J.van der Woude, F.H.Claas, R.Wolterbeek, and J.P.Vandenbroucke. 1993. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol. 129(3):242-249.
10. Bedard, K.M., M.P.Underbrink, H.L.Howie, and D.A.Galloway. 2008. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol. 82(8):3894-3902.
11. Bell, E., S.Sher, B.Hull, C.Merrill, S.Rosen, A.Chamson, D.Asselineau, L.Dubertret, B.Coulomb, C.Lapiere, B.Nusgens, and Y.Neveux. 1983. The reconstitution of living skin. J Invest Dermatol. 81(suppl.1): S2-S10.
12. Berg, R.J., S.C.de Bueger, K.Guikers, H.vanWeelden, W.A.van Vloten, J.C.van der Leun, and F.R.de Gruijl. 1995. Induction and disappearance of thymine dimers in human skin exposed to UVB radiation: flow cytometric measurements in replicating and nonreplicating epidermal cells. Photochem Photobiol. 62(6):970-975.
13. Berger, T.G., W.S.Sawchuk, C.Leonardi, A.Langenberg, J.Tappero, and P.E.Leboit. 1991. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol. 124(1):79-83.
14. Berkhout, R.J., J.N.Bouwes Bavinck, and J.terSchegget. 2000. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J. Clin. Microbiol. 38(6):2087-2096.
15. Bernard, H.U. 2005. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol. 32(suppl.1):S1-S6.
16. Boshart, M., L.Gissmann, H.Ikenberg, A.Kleinheinz, W.Scheurlen, and H.zurHausen. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3(5):1151-1157.
17. Boxman, I.L., R.J.Berkhout, L.H.Mulder, M.C.Wolkers, J.N.Bouwes Bavinck, B.J.Vermeer, and J.terSchegget. 1997. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol. 108(5):712-715.
18. Boxman, I.L., L.H.Mulder, F.Noya, V.deWaard, S.Gibbs, T.R.Broker, F.tenKate, L.T.Chow, and J.terSchegget. 2001. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures. J. Invest Dermatol. 117(6):1397-1404.
19. Boxman, I.L., L.H.Mulder, A.Russell, J.N.Bouwes Bavinck, A.Green, and J.terSchegget. 1999. Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol. 141(2):246-249.
20. Boyle, J., R.M.MacKie, J.D.Briggs, B.J.Junor, and T.C.Aitchison. 1984. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet. 1(8379):702-705.
21. Brash, D.E., J.A.Rudolph, J.A.Simon, A.Lin, G.J.McKenna, H.P.Baden, A.J.Halperin, and J.Ponten. 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 88(22):10124-10128.
22. Breuninger, H., F. Bootz , A. Hauschild, R.D. Kortmann, K. Wolff, E. Stockfleth, M. Szeimies, R. Rompel, C. Garbe. 2008. Short German guidelines: squamous cell carcinoma. J Dtsch Dermatol Ges. 6(suppl 1): S5-8.
23. Caldeira, S., I.Zehbe, R.Accardi, I.Malanchi, W.Dong, M.Giarre, E.M.de Villiers, R.Filotico, P.Boukamp, and M.Tommasino. 2003. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77(3):2195-2206.
24. Cheng, S., D.C.Schmidt-Grimminger, T.Murant, T.R.Broker, and L.T.Chow. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9(19):2335-2349.
25. Chiquet-Ehrismann, R. and M.Chiquet. 2003. Tenascins: regulation and putative functions during pathological stress. J Pathol. 200(4):488-499.
26. Chow, L.T. and T.R.Broker. 1997. In vitro experimental systems for HPV: epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences. Clin. Dermatol. 15(2):217-227.
27. Dang, C., M.Gottschling, J.Roewert, T.Forschner, E.Stockfleth, and I.Nindl. 2006a. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br. J. Dermatol. 155(4):763-770.
28. Dang, C., A.Koehler, T.Forschner, P.Sehr, K.Michael, M.Pawlita, E.Stockfleth, and I.Nindl. 2006b. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br. J. Dermatol. 155(1):129-136.
29. Darr, D. and I.Fridovich. 1994. Free radicals in cutaneous biology. J Invest Dermatol. 102(5):671-675.
30. de Gruijl, F.R. and P.D.Forbes. 1995. UV-induced skin cancer in a hairless mouse model. Bioessays. 17(7).651-660.
31. de Villiers, E.M., C.Fauquet, T.R.Broker, H.U.Bernard, and H.zurHausen. 2004. Classification of papillomaviruses. Virology 324(1):17-27.
32. DePinho, R.A. 2000. The age of cancer. Nature. 408(6809):248-254.
33. Diepgen, T.L. and V.Mahler. 2002. The epidemiology of skin cancer. Br J Dermatol. 146(suppl.61):1-6.
34. Donnellan, R. and R.Chetty. 1999. Cyclin E in human cancers. Faseb J. 13(8):773-780.
35. Doorbar, J. 2005. The papillomavirus life cycle. J. Clin. Virol. 32(suppl.1):S7-S15.
36. Dyson, N., P.M.Howley, K.Münger, and E.Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243(4893):934-937.
37. Elbel, M., S.Carl, S.Spaderna, and T.Iftner. 1997. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential. Virology. 239(1):132-149.
38. Elgui de, O.D. 2007. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett. 247(2):182-196.
39. Euvrard, S., J.Kanitakis, and A.Claudy. 2003. Skin cancers after organ transplantation. N Engl J Med. 348(17):1681-1691.
40. Favre, M., G.Orth, O.Croissant, and M.Yaniv. 1977. Human papillomavirus DNA: physical mapping of the cleavage sites of Bacillus amyloliquefaciens (BamI) and Haemophilus parainfluenzae (HpaII) endonucleases and evidence for partial heterogeneity. J Virol. 21(3):1210-1214.
41. Fu, B., J.Quintero, C.C.Baker, 2003. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes. Cancer Re s. 63 (22):7815-7824.
42. Fehrmann, F. and L.A.Laimins. 2003. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene. 22(33):5201-5207.
43. Gewin, L. and D.A.Galloway. 2001. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J Virol. 75(15):7198-7201.
44. Grossman, S.R. and L.A.Laimins. 1989. E6 protein of human papillomavirus type 18 binds zinc. Oncogene. 4(9):1089-1093.
45. Hauschild, A., H. Breuninger, R. Kaufmann, R.D. Kortmann, V. Schwipper, J. Werner, J. Reifenberger, T. Dirscha, C. Garbe. 2008. Short German guidelines: basal cell carcinoma. J Dtsch D ermatol Ges. 6(suppl 1): S2-4.
46. Halbert, C.L., G.W.Demers, and D.A.Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol. 65(1).473-478.
47. Halbert, C.L., G.W.Demers, and D.A.Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol. 66(4):2125-2134.
48. Hall, A., C.J.Marshall, N.K.Spurr, and R.A.Weiss. 1983. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature. 303(5916):396-400.
49. Hanahan, D. and R.A.Weinberg. 2000. The hallmarks of cancer. Cell. 100(1):57-70.
50. Harwood, C.A., J.M.McGregor, C.M.Proby, and J.Breuer. 1999. Human papillomavirus and the development of non-melanoma skin cancer. J. Clin. Pathol. 52(4):249-253.
51. Harwood, C.A., T.Surentheran, J.M.McGregor, P.J.Spink, I.M.Leigh, J.Breuer, and C.M.Proby. 2000. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J. Med. Virol. 61(3):289-297.
52. Harwood, C.A., T.Surentheran, P.Sasieni, C.M.Proby, C.Bordea, I.M.Leigh, F.Wojnarowska, J.Breuer, and J.M.McGregor. 2004. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br. J. Dermatol. 150(5):949-957.
53. Hawley-Nelson, P., K.H.Vousden, N.L.Hubbert, D.R.Lowy, and J.T.Schiller. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. Embo J. 8(12):3905-3910.
54. Hopfl, R., G.Bens, U.Wieland, A.Petter, B.Zelger, P.Fritsch, and H.Pfister. 1997. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol. 108(1):53-56.
55. Hudson, J.B., M.A.Bedell, D.J.McCance, and L.A.Laiminis. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol. 64(2):519-526.
56. Iftner, T., S.Bierfelder, Z.Csapo, and H.Pfister. 1988. Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J Virol. 61(10):3655-3661.
57. Jablonska, S., J.Dabrowski, and K.Jakubowicz. 1972. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res. 32(3).583-589.
58. Jablonska, S., G.Orth, M.Jarzabek-Chorzelska, S.Obalek, G.Rzesa, O.Croissant, and M.Favre. 1979. New developments relating to papillomaviruses. Hautarzt. 30(8):411-417.
59. Jackson, S., C.Harwood, M.Thomas, L.Banks, and A.Storey. 2000. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14(23):3065-3073.
60. Joyce, J.G., J.S.Tung, C.T.Przysiecki, J.C.Cook, E.D.Lehman, J.A.Sands, K.U.Jansen, and P.M.Keller. 1999. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem. 274(9):5810-5822.
61. Junqueira, L.C., J.Carneiro, and T.H.Schiebler. 1996. Histologie. Springer, 4.Auflage.
62. Karagas, M.R., H.H.Nelson, P.Sehr, T.Waterboer, T.A.Stukel, A.Andrew, A.C.Green, J.N.Bavinck, A.Perry, S.Spencer, J.R.Rees, L.A.Mott, and M.Pawlita. 2006. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst. 98(6):389-395.
63. Kim, N.W., M.A.Piatyszek, K.R.Prowse, C.B.Harley, M.D.West, P.L.Ho, G.M.Coviello, W.E.Wright, S.L.Weinrich, and J.W.Shay. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science. 266(5193):2011-2015.
64. Kiyono, T., S.A.Foster, J.I.Koop, J.K.McDougall, D.A.Galloway, and A.J.Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396(6706):84-88.
65. Klingelhutz, A.J., S.A.Foster, and J.K.McDougall. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 386(6569):79-82.
66. Köhler, A., T.Forschner, T.Meyer, C.Ulrich, M.Gottschling, E.Stockfleth, and I.Nindl. 2007. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br. J. Dermatol. 156(5):1078-1080.
67. Kremsdorf, D., M.Favre, S.Jablonska, S.Obalek, L.A.Rueda, M.A.Lutzner, C.Blanchet-Bardon, P.C.vanVoorstVader, and G.Orth. 1984. Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol. 52(3):1013-1018.
68. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227(5259):680-685.
69. Laimins, L.A. 1993. The biology of human papillomaviruses: from warts to cancer. Infect Agents Dis. 2(2):74-86.
70. Lane, D.P. and L.V.Crawford. 1979. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278(5701):261-263.
71. Luria, S.E., J.N.Adams, and R.C.Ting. 1960. Transduction of lactose-utilizing ability among strains of E. coli and S. dysenteriae and the properties of the transducing phage particles. Virology. 12:348-390.
72. Manes, S., E.Mira, C.Gomez-Mouton, R.A.Lacalle, and C.Martinez. 2000. Cells on the move: a dialogue between polarization and motility. I UBMB Life. 49(2):89-96.
73. Marks, R., G.Rennie, and T.S.Selwood. 1988. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1(8589):795-797.
74. Meyer, T., R.Arndt, I.Nindl, C.Ulrich, E.Christophers, and E.Stockfleth. 2003. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transpl Int. 16(3).146-153.
75. Miller, A.D. and F.Chen. 1996. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol. 70(8):5564-5571.
76. Miller, D.L. and M.A.Weinstock. 1994. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 30(5pt.1):774-778.
77. Moll, R., M.Divo, and L.Langbein. 2008. The human keratins: biology and pathology. Histochem Cell Biol. 129(6):705-733.
78. Moll, R., W.W.Franke, B.Volc-Platzer, and R.Krepler. 1982. Different keratin polypeptides in epidermis and other epithelia of human skin: a specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas. J Cell Biol. 95(1):285-295.
79. Münger, K. and P.M.Howley. 2002. Human papillomavirus immortalization and transformation functions. Virus Res. 89(2).213-228.
80. Münger, K., B.A.Werness, N.Dyson, W.C.Phelps, E.Harlow, and P.M.Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. Embo J. 8(13).4099-4105.
81. Munoz, N., F.X.Bosch, S.deSanjose, R.Herrero, X.Castellsague, K.V.Shah, P.J.Snijders, and C.J.Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348(6):518-527.
82. Murphy, G.F., T.C.Flynn, R.H.Rice, and G.S.Pinkus. 1984. Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J Invest Dermatol. 82(5).453-457.
83. Murphy, N., M.Ring, A.G.Killalea, V.Uhlmann, M.O'Donovan, F.Mulcahy, M.Turner, E.McGuinness, M.Griffin, C.Martin, O.Sheils, and J.J.O'Leary. 2003. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol. 56(1):5663.
84. Nakamura, T.M., G.B.Morin, K.B.Chapman, S.L.Weinrich, W.H.Andrews, J.Lingner, C.B.Harley, and T.R.Cech. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277(5328):955-959.
85. Narechania, A., Z.Chen, R.Desalle, and R.D.Burk. 2005. Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol. 79(24):15503-15510.
86. Nataraj, A.J., J.C.Trent, and H.N.Ananthaswamy. 1995. p53 gene mutations and photocarcinogenesis. Photochem Photobiol. 62(2):218-230.
87. Naviaux, R.K. and I.M.Verma. 1992. Retroviral vectors for persistent expression in vivo. Curr Opin Biotechnol. 3(5):540-547.
88. Nindl, I., M.Gottschling, N.Krawtchenko, M.D.Lehmann, J.Rowert-Huber, J.Eberle, E.Stockfleth, and T.Forschner. 2007. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis. Br. J. Dermatol. 156(suppl. 3):34-39.
89. Nindl, I., A.Koehler, T.Meyer, T.Forschner, C.J.Meijer, P.J.Snijders, W.Sterry, and E.Stockfleth. 2006. Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases. Br. J. Dermatol. 154(4):797-799.
90. Nindl, I., T.Meyer, T.Schmook, C.Ulrich, R.Ridder, H.Audring, W.Sterry, and E.Stockfleth. 2004. Human papillomavirus and overexpression of p16INK4a in nonmelanoma skin cancer. Dermatol. Surg. 30(3):409-414.
91. Noel, J.C., O.Detremmerie, M.O.Peny, M.Candaele, A.Verhest, M.Heenen, and G.DeDobbeleer. 1994. Transformation of common warts into squamous cell carcinoma on sun-exposed areas in an immunosuppressed patient. Dermatology. 189(3):308-311.
92. Orth, G., S.Jablonska, M.Favre, O.Croissant, M.Jarzabek-Chorzelska, and G.Rzesa. 1978. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S A. 75(3):1537-1541.
93. Ostrow, R.S., M.Bender, M.Niimura, T.Seki, M.Kawashima, F.Pass, and A.J.Faras. 1982. Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci U S A. 79(5):1634-1638.
94. Palefsky, J. 1991. Human papillomavirus infection among HIV-infected individuals. Implications for development of malignant tumors. Hematol Oncol Clin North Am. 5(2):357-370.
95.Parkin, D.M. 2001. Global cancer statistics in the year 2000. Lancet Oncol. 2(9):533-543.
96. Parkin, D.M., F.Bray, J.Ferlay, and P.Pisani. 2005. Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108.
97. Parry, D., S.Bates, D.J.Mann, and G.Peters. 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. Embo J. 14(3):503-511.
98. Pfister, H. 2003. Chapter 8: Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr (31):52-56.
99. Pfister, H. and P.G.Fuchs. 1987. Papillomaviruses and human deseases. In Papillomaviruses: particles, genome organization and proteins, pp.1-18. Edited by K. Syrjanen, L. Gissmann & L.G.Koss.
100. Pfister, H., P.G.Fuchs, S.Majewski, S.Jablonska, I.Pniewska, and M.Malejczyk. 2003. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res. 295(7):273-279.
101. Plug-DeMaggio, A.W., T.Sundsvold, M.A.Wurscher, J.I.Koop, A.J.Klingelhutz, and J.K.McDougall. 2004. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene. 23(20):3561-3571.
102. Poumay, Y., F.Dupont, S.Marcoux, M.Leclercq-Smekens, M.Herin, and A.Coquette. 2004. A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch Dermatol Res. 296(5):203-211.
103. Prunieras, M., M.Regnier, and D.Woodley. 1983. Methods for cultivation of keratinocytes with an air-liquid interface. J Invest Dermatol. 81(suppl.1):S28-S33.
104. Purdie, K.J., T.Surentheran, J.C.Sterling, L.Bell, J.M.McGregor, C.M.Proby, C.A.Harwood, and J.Breuer. 2005. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J. Invest Dermatol. 125(1):98-107.
105. Regnier, M., D.Caron, U.Reichert, and H.Schaefer. 1992. Reconstructed human epidermis: a model to study in vitro the barrier function of the skin. Skin Pharmacol. 5(1):49-56.
106. Rheinwald, J.G. and H.Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6(3):331-343.
107. Rohde, V., H.J.Sommerfeld, H.P.Sattler, B.Wullich B. 1998. Telomerase in tumors: facts and perspectives. Urologe[A]. 37(4):386-394.
108. Rünger, T.M., B.Epe, and K.Möller. 1995. Processing of directly and indirectly ultraviolet-induced DNA damage in human cells. Recent Results Cancer Res. 139:31-42.
109. Salasche, S.J. 2000. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 42(pt.2)4-7.
110.Sambrook, J., Fritsch, E. F., Maniatis, T. (1989). Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
111. Sato, H., S.Watanabe, A.Furuno, and K.Yoshiike. 1989. Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 cells: immunofluorescence detection of the nuclear E7 protein. Virology. 170(1):311-315.
112. Scheffner, M., B.A.Werness, J.M.Huibregtse, A.J.Levine, and P.M.Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63(6):1129-1136.
113. Scheurlen, W., L.Gissmann, G.Gross, and H.zurHausen. 1986. Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer. 37(4):505-510.
114. Schlegel, R., W.C.Phelps, Y.L.Zhang, and M.Barbosa. 1988. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. Embo J. 7(10):3181-3187.
115. Schmitt, A., J.B.Harry, B.Rapp, F.O.Wettstein, and T.Iftner. 1994. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J Virol. 68(11):7051-7059.
116. Schwarz, E., U.K.Freese, L.Gissmann, W.Mayer, B.Roggenbuck, A.Stremlau, and H.zurHausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 314(6006):111-114.
117. Shafti-Keramat, S., A.Handisurya, E.Kriehuber, G.Meneguzzi, K.Slupetzky, and R.Kirnbauer. 2003. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol. 77(24):13125-13135.
118. Shamanin, V., H.zurHausen, D.Lavergne, C.M.Proby, I.M.Leigh, C.Neumann, H.Hamm, M.Goos, U.F.Haustein, E.G.Jung, G.Plewig, H.Wolff, and E.M.de Villiers. 1996. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst. 88(12):802-811.
119. Shay, J.W., Y.Zou, E.Hiyama, and W.E.Wright. 2001. Telomerase and cancer. Hum Mol Genet. 10(7):677-685.
120. Shea, C. and Parrish.J. 1993. Non ionising radiation and the skin. In:
Physiology, Biochemistry, and Molecular Biology of the Skin.Edited by Goldsmith, L.
121. Smith, P.K., R.I.Krohn, G.T.Hermanson, A.K.Mallia, F.H.Gartner, M.D.Provenzano, E.K.Fujimoto, N.M.Goeke, B.J.Olson, and D.C.Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem. 150(1):76-85.
122. Smola-Hess, S., J.Pahne, C.Mauch, P.Zigrino, H.Smola, and H.J.Pfister. 2005. Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol. 86(pt.5):1291-1296.
123. Specht, C., I.Stoye, and C.C.Müller-Goymann. 1998. Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies. Eur J Pharm Biopharm. 46(3):273-278.
124. Steger, G. and H.Pfister. 1992. In vitro expressed HPV 8 E6 protein does not bind p53. Arch Virol. 125(1-4):355-360.
125. Steinert, P.M. and L.N.Marekov. 1995. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 270(30):17702-17711.
126. Stockfleth, E., C.Ulrich, T.Meyer, R.Arndt, and E.Christophers. 2001. Skin diseases following organ transplantation-risk factors and new therapeutic approaches. Transplant Proc. 33(1-2):1848-53.
127. Stubenrauch, F. and L.A.Laimins. 1999. Human papillomavirus life cycle: active and latent phases. - Semin Cancer Biol. 9(6):379-386.
128. Thomas, J.T., S.T.Oh, S.S.Terhune, and L.A.Laimins. 2001. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J Virol. 75(16):7564-7571.
129. Thomas, M. and L.Banks. 1998. Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene. 17(23):2943-2954.
130. Tilgen, W., P.Boukamp, D.Breitkreutz, R.T.Dzarlieva, M.Engstner, D.Haag, and N.E.Fusenig. 1983. Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res. 43(12pt.1):5995-6011.
131. Tomkova, H., W.Fujimoto, and J.Arata. 1997. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases. Br J Dermatol. 137(5):703-708.
132. van Duinen, C.M., G.J.Fleuren, and J.A.Bruijn. 1994. The extracellular matrix in pigmented skin lesions: an immunohistochemical study. Histopathology. 24(1):33-40.
133. van Regenmortel, M.H., M.A.Mayo, C.M.Fauquet, and J.Maniloff. 2000. Virus nomenclature: consensus versus chaos. Arch Virol. 32.
134. Veldman, T., I.Horikawa, J.C.Barrett, and R.Schlegel. 2001. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol. 75(9):4467-4472.
135. Walboomers, J.M., M.V.Jacobs, M.M.Manos, F.X.Bosch, J.A.Kummer, K.V.Shah, P.J.Snijders, J.Peto, C.J.Meijer, and N.Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189(1):1-3.
136. Waterboer, T., D.Abeni, F.Sampogna, A.Rother, C.Masini, P.Sehr, K.M.Michael, and M.Pawlita. 2008. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol. 159(2):457-459.
137. Werness, B.A., A.J.Levine, and P.M.Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248(4951):76-79.
138. Zantema, A., P.I.Schrier, A.Davis-Olivier, T.vanLaar, R.T.Vaessen, and A.J.van der Eb. 1985. Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol Cell Biol. 5(11):3084-3091.
139. Zheng, Z.M. and C.C.Baker. 2006. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci. 11:2286-2302.
140. Ziegler, A., D.J.Leffell, S.Kunala, H.W.Sharma, M.Gailani, J.A.Simon, A.J.Halperin, H.P.Baden, P.E.Shapiro, and A.E.Bale. 1993. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 90(9):4216-4220.
141. Zieske, J.D., V.S.Mason, M.E.Wasson, S.F.Meunier, C.J.Nolte, N.Fukai, B.R.Olsen, and N.L.Parenteau. 1994. Basement membrane assembly and differentiation of cultured corneal cells: importance of culture environment and endothelial cell interaction. Exp Cell Res. 214(2):621-633.
142. zur Hausen, H. 1987. Papillomaviruses in human cancer. Cancer. 59(10):1692-1696.
143. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2(5):342-350.
© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme. | ||
DiML DTD Version 4.0 | Zertifizierter Dokumentenserver der Humboldt-Universität zu Berlin | HTML-Version erstellt am: 24.01.2014 |